SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-07
👔
Attovia Therapeutics, Inc.
@ATTO_InsiderForm 4 Filing: Sanofi Buys $5.1M of $ATTO
INSIDER PURCHASE
⚡ MATERIALITY: 8/10
corporate issuer
Attovia Therapeutics, Inc.
Ticker: $ATTO
Transaction Value
$5.1M
Price/Share: $4.71
transaction date
2026-08-06
Shares: 1,082,855
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Sanofi, holds the title of 10% Owner at Attovia Therapeutics, Inc..
On 2026-08-06, the insider transacted 1,082,855 shares.The shares were transacted at a weighted average price of $4.71 per share, resulting in a total market-relevant value of $5.1M.
Executive Summary Summary
Sanofi (10% Owner) bought $5.1M of $ATTO
Post-Transaction Position: 1,082,855 shares
SEC Accession No: 0001193125-26-340173 (CIK: 1121404)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.